A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) C07K 14/18 (2006.01)
Patent
CA 2694127
The invention concerns the use of recombinant clonotypic immunoglobulins (Ig) as a vaccine in the treatment of HCV-related and non HCV-related lymphoproliferations, in particular the use of recombinant proteins with immunogenic properties derived from protein segments VK3-20 and VK3-15 of Ig light chains derived from patients with lymphoproliferations.
L'invention concerne l'utilisation d'immunoglobulines (Ig) clonotypiques recombinantes en tant que vaccin pour le traitement de lymphoproliférations liées au VHC ou non liées au VHC, en particulier l'utilisation de protéines recombinantes ayant des propriétés immunogènes dérivées des segments de protéine VK3-20 et VK3-15 des chaînes légères d'Ig dérivées de patients présentant des lymphoproliférations.
Castiglioni Sonia
de Re Valli
Dolcetti Riccardo
Gasparotto Daniela
Guidoboni Massimo
Areta International S.r.l.
Robic
LandOfFree
Idiotypic vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Idiotypic vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Idiotypic vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1370501